ethylmethylhydroxypyridine-succinate and Myocardial-Ischemia

ethylmethylhydroxypyridine-succinate has been researched along with Myocardial-Ischemia* in 1 studies

Trials

1 trial(s) available for ethylmethylhydroxypyridine-succinate and Myocardial-Ischemia

Article	Year
[Effect of cytoprotectors on lipid metabolism and C-reactive protein in patients with coronary heart disease]. Likars'ka sprava, 2012, Issue:7 The results of the study parameters lipid profile and C-reactive protein (C-RP) in patients with angina pectoris after applying meksykoru. Combined treatment with meksykoru to correct the atherogenic lipid profile and CRP helped reduce content CRP, total cholesterol, low-density lipoprotein cholesterol, triglycerides, factor aterohenosti and raise HDL cholesterol. Topics: Angina, Stable; Angina, Unstable; Antioxidants; C-Reactive Protein; Cytoprotection; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Lipids; Male; Middle Aged; Myocardial Ischemia; Pyridines; Treatment Outcome	2012

Article

Year

[Effect of cytoprotectors on lipid metabolism and C-reactive protein in patients with coronary heart disease].

Likars'ka sprava, 2012, Issue:7

The results of the study parameters lipid profile and C-reactive protein (C-RP) in patients with angina pectoris after applying meksykoru. Combined treatment with meksykoru to correct the atherogenic lipid profile and CRP helped reduce content CRP, total cholesterol, low-density lipoprotein cholesterol, triglycerides, factor aterohenosti and raise HDL cholesterol.

Topics: Angina, Stable; Angina, Unstable; Antioxidants; C-Reactive Protein; Cytoprotection; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Lipids; Male; Middle Aged; Myocardial Ischemia; Pyridines; Treatment Outcome

2012